We are live on
!
Find out more
Natixis Advisors Portfolio holdings
AUM
$71.9B
1-Year Est. Return
28.03%
This Fund
S&P 500
This Quarter
Est. Return
-3.85%
1 Year Est. Return
+28.03%
3 Year Est. Return
+95.12%
5 Year Est. Return
+131.42%
10 Year Est. Return
+475.22%
AUM
$23.6B
AUM Growth
+$900M
(+4%)
Cap. Flow
+$1.81B
Cap. Flow
% of AUM
7.66%
Top 10 Holdings %
Top 10 Hldgs %
15.31%
Holding
1,542
New
90
Increased
818
Reduced
532
Closed
102
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$149M |
| 2 |
Apple
AAPL
|
+$102M |
| 3 |
Amazon
AMZN
|
+$85.4M |
| 4 |
Vanguard Morningstar Value ETF
VTV
|
+$67.1M |
| 5 |
Microsoft
MSFT
|
+$51M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$31.5M |
| 2 |
Nutrien
NTR
|
+$29.5M |
| 3 |
AT&T
T
|
+$28.9M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$27.6M |
| 5 |
Sanofi
SNY
|
+$27.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.61% |
| 2 | Healthcare | 14.15% |
| 3 | Financials | 13.71% |
| 4 | Consumer Discretionary | 9.67% |
| 5 | Industrials | 9.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1226
Aveanna Healthcare
AVAH
$2.11B
| $633K | ﹤0.01% |
421,811
+29,844
| +8% | +$61.3K |
|
1227
Adeia
ADEA
$2.8B
| $631K | ﹤0.01% |
91,733
+18,579
| +25% | +$76.3K |
|
|
AJRD
1228
DELISTED
Aerojet Rocketdyne Holdings
AJRD
| $627K | ﹤0.01% |
15,688
+2,964
| +23% | +$125K |
|
|
CIM
1229
Chimera Investment
CIM
$1.06B
| $626K | ﹤0.01% |
39,995
-25,408
| -39% | -$662K |
|
1230
Viatris
VTRS
$20.7B
| $626K | ﹤0.01% |
73,522
-47,172
| -39% | -$464K |
|
1231
Gibraltar Industries
ROCK
$1.27B
| $623K | ﹤0.01% |
15,231
-1,173
| -7% | -$50K |
|
1232
MP Materials
MP
$7.42B
| $622K | ﹤0.01% |
22,767
+3,957
| +21% | +$129K |
|
1233
Woodside Energy
WDS
$44.4B
| $617K | ﹤0.01% |
30,618
-31,513
| -51% | -$695K |
|
1234
Banner Corp
BANR
$2.37B
| $615K | ﹤0.01% |
+10,406
| New | +$628K |
|
1235
nLIGHT
LASR
$3.71B
| $614K | ﹤0.01% |
64,937
+4,224
| +7% | +$48.7K |
|
|
PACW
1236
DELISTED
PacWest Bancorp
PACW
| $614K | ﹤0.01% |
27,191
-47,061
| -63% | -$1.27M |
|
1237
First Hawaiian
FHB
$3.4B
| $613K | ﹤0.01% |
24,899
+10,702
| +75% | +$270K |
|
1238
National Bank Holdings
NBHC
$1.9B
| $612K | ﹤0.01% |
16,536
-172
| -1% | -$6.91K |
|
|
XHR
1239
Xenia Hotels & Resorts
XHR
$1.85B
| $611K | ﹤0.01% |
44,328
+21,079
| +91% | +$336K |
|
1240
Rapid7
RPD
$634M
| $609K | ﹤0.01% |
14,204
-3,599
| -20% | -$222K |
|
1241
Vanguard International High Dividend Yield ETF
VYMI
$20.7B
| $604K | ﹤0.01% |
+11,604
| New | +$670K |
|
|
CO
1242
DELISTED
Global Cord Blood Corporation
CO
| $601K | ﹤0.01% |
201,151
+1,271
| +0.6% | +$3.12K |
|
|
ALTR
1243
DELISTED
Altair Engineering Inc
ALTR
| $600K | ﹤0.01% |
+13,561
| New | +$711K |
|
1244
iShares Core MSCI Emerging Markets ETF
IEMG
$149B
| $599K | ﹤0.01% |
13,943
+3,447
| +33% | +$165K |
|
1245
Diamondrock Hospitality Co
DRH
$2.64B
| $596K | ﹤0.01% |
79,380
+21,980
| +38% | +$194K |
|
1246
Sanmina
SANM
$9.83B
| $589K | ﹤0.01% |
12,780
+1,847
| +17% | +$86.1K |
|
1247
Progyny
PGNY
$2.47B
| $588K | ﹤0.01% |
15,858
+856
| +6% | +$32.1K |
|
1248
Semtech
SMTC
$10.7B
| $581K | ﹤0.01% |
19,750
-719
| -4% | -$33.7K |
|
1249
Fox Class B
FOX
$22B
| $579K | ﹤0.01% |
20,309
+5,850
| +40% | +$183K |
|
1250
Macerich
MAC
$7.22B
| $574K | ﹤0.01% |
72,348
+38,509
| +114% | +$374K |
|
Similar funds
BC
CBU
Natixis Advisors's Q3 2022 Portfolio in Review
As of Q3 2022, Natixis Advisors held 1,542 positions worth $23.6B, up 4% from $22.7B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Natixis Advisors deployed $1.81B of net new capital in Q3 2022, opening 90 new positions and adding to 818 existing holdings. Its largest new stake was Chemed: 52,930 shares worth $23.1M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Vanguard Morningstar Total Stock Market ETF, an estimated $31.5M trimmed.
- Natixis Advisors's largest Q3 2022 buy was Chemed: 52,930 shares worth $23.1M.
- Natixis Advisors added most to Vanguard FTSE Developed Markets ETF in Q3 2022, an estimated $149M increase.
- Natixis Advisors's biggest Q3 2022 reduction was Vanguard Morningstar Total Stock Market ETF, cutting an estimated $31.5M.
- Natixis Advisors fully exited Domino's in Q3 2022, selling an estimated $4.15M.
- Natixis Advisors's ten largest holdings make up 15% of its $23.6B portfolio in Q3 2022.
- Natixis Advisors opened 90 new positions and closed 102 in Q3 2022.
- Natixis Advisors's portfolio value rose 4% quarter-over-quarter to $23.6B.
Based on Natixis Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.